Project deliverable Open Access
Miceli, Rosalba
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd"> <identifier identifierType="DOI">10.5281/zenodo.4142787</identifier> <creators> <creator> <creatorName>Miceli, Rosalba</creatorName> <givenName>Rosalba</givenName> <familyName>Miceli</familyName> <affiliation>Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy</affiliation> </creator> </creators> <titles> <title>G-DEFINER CRFs</title> </titles> <publisher>Zenodo</publisher> <publicationYear>2020</publicationYear> <subjects> <subject>Clinical Oncology, Immunotherapy, Sex, Gender, Biology, Biostatistics. Bioinformatics</subject> </subjects> <dates> <date dateType="Issued">2020-10-27</date> </dates> <language>en</language> <resourceType resourceTypeGeneral="Text">Project deliverable</resourceType> <alternateIdentifiers> <alternateIdentifier alternateIdentifierType="url">https://zenodo.org/record/4142787</alternateIdentifier> </alternateIdentifiers> <relatedIdentifiers> <relatedIdentifier relatedIdentifierType="DOI" relationType="IsVersionOf">10.5281/zenodo.4142786</relatedIdentifier> </relatedIdentifiers> <rightsList> <rights rightsURI="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International</rights> <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights> </rightsList> <descriptions> <description descriptionType="Abstract"><p><strong><a href="https://gdefiner.net/">https://gdefiner.net/</a> </strong></p> <p><strong>Project: &quot;Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment&quot; </strong></p> <p><strong>(G-DEFINER). </strong></p> <p><strong>Clinical study CRFs. (DOI of the Study Protocol: 10.5281/zenodo.4142124)</strong></p> <p>This is a multicenter observational prospective clinical study aimed at investigating the inequalities between female (F) and male (M) patients in the development of immune-related adverse events (irAEs) associated with immunotherapy treatment. The evaluation of the differences in terms of irAEs incidence concerning biological aspects will be integrated by the exploration of their gender dimension.</p></description> </descriptions> <fundingReferences> <fundingReference> <funderName>European Commission</funderName> <funderIdentifier funderIdentifierType="Crossref Funder ID">10.13039/100010661</funderIdentifier> <awardNumber awardURI="info:eu-repo/grantAgreement/EC/H2020/741874/">741874</awardNumber> <awardTitle>ERA-NET Cofund Promoting Gender Equality in H2020 and the ERA</awardTitle> </fundingReference> </fundingReferences> </resource>
All versions | This version | |
---|---|---|
Views | 104 | 104 |
Downloads | 110 | 110 |
Data volume | 34.6 MB | 34.6 MB |
Unique views | 79 | 79 |
Unique downloads | 88 | 88 |